Investing Profile

Houman Ashrafian

InvestorVC
Managing Partner at SV Health Investors
Photo of Houman Ashrafian, Managing Partner at SV Health Investors

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
SV Health Investors Managing Partner
$100K - $5.0M
$1.5M
7
£200M
CompanyStageDateRound SizeTotal Raised
Therini Bio
Series AApr 2023$36M
$62M
Co-investors: Jim Trenkle (Sanofi Ventures), Laurence Barker (SV Health Investors), Mike Ross (SV Health Investors), Pascal Levensohn (Dolby Family Ventures)
Quell Therapeutics
Series BNov 2021$160M
$160M
Mestag Therapeutics
SeedApr 2021$11M
$11M
Alchemab Therapeutics
Series AApr 2021$83M
$83M
Co-investors: Andrew Levin (RA Capital)
Catamaran Bio
Series ANov 2020$42M
$47M
Co-investors: Jack Kenney (SV Health Investors), Maina Bhaman (Soffinova Partners), Caroline Gaynor (Lightstone Ventures)
Enara Bio
Series ANov 2019$18M
$51M
Co-investors: Rana Al-Hallaq (Pfizer Venture Investments)
Sitryx Therapeutics
Series AOct 2018$30M
$30M
Co-investors: Maina Bhaman (Soffinova Partners)